GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,585,000 | +2.1% | 87,943 | +0.5% | 0.00% | 0.0% |
| Q3 2016 | $2,532,000 | +4.3% | 87,540 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $2,427,000 | +8.5% | 93,730 | +3.8% | 0.00% | 0.0% |
| Q1 2016 | $2,236,000 | -28.6% | 90,258 | +1.5% | 0.00% | -25.0% |
| Q4 2015 | $3,130,000 | +66.4% | 88,934 | +0.1% | 0.00% | +33.3% |
| Q3 2015 | $1,881,000 | -23.9% | 88,881 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $2,472,000 | +7.4% | 88,940 | +18.0% | 0.00% | 0.0% |
| Q1 2015 | $2,302,000 | -3.1% | 75,353 | +1.4% | 0.00% | 0.0% |
| Q4 2014 | $2,375,000 | +42.4% | 74,296 | +26.1% | 0.00% | +50.0% |
| Q3 2014 | $1,668,000 | +3.3% | 58,907 | +0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,614,000 | +31.8% | 58,895 | +26.6% | 0.00% | 0.0% |
| Q1 2014 | $1,225,000 | -9.7% | 46,519 | +0.4% | 0.00% | 0.0% |
| Q4 2013 | $1,356,000 | -6.0% | 46,319 | -1.8% | 0.00% | 0.0% |
| Q3 2013 | $1,443,000 | +3.2% | 47,183 | +7.0% | 0.00% | 0.0% |
| Q2 2013 | $1,398,000 | – | 44,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,458,100 | $76,914,000 | 3.78% |
| Baker Brothers Advisors | 13,789,936 | $431,487,000 | 3.66% |
| Millrace Asset Group, Inc. | 147,500 | $4,081,000 | 1.98% |
| EMORY UNIVERSITY | 79,591 | $2,490,000 | 1.78% |
| Aurora Investment Counsel | 56,055 | $1,754,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 80,903 | $2,531,000 | 0.47% |
| Spark Investment Management LLC | 101,400 | $3,172,000 | 0.20% |
| ALGERT GLOBAL LLC | 28,720 | $899,000 | 0.17% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 64,346 | $2,013,000 | 0.15% |
| Alambic Investment Management, L.P. | 21,600 | $676,000 | 0.09% |